Bioheart, Inc. · Sunrise, FL United States ·(Pink Sheets: BHRT)
Company Description
View Bioheart, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Broken hearts are no fun, but damaged hearts are worse and Bioheart aims to help. The biotech company is focused on the discovery, development, and commercialization of therapies treating heart damage. Because the heart does not have cells to naturally repair itself, Bioheart is exploring the use of cells derived from the patient's own thigh muscle to improve cardiac function after a heart has been damaged by a heart attack. Its lead candidate, MyoCell, uses precursor muscle cells called myoblasts to strengthen scar tissue with living muscle tissue. The company is also developing a number of proprietary techniques and processes used to obtain and inject MyoCell. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Bioheart, Inc. Financials
| Company Type | Public - Pink Sheets: BHRT Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $0.2 |
| 2008 Employees | 28 |
Bioheart, Inc. Executives
14 executives listed for Bioheart, Inc.'s Sunrise, FL location.
| Title | Name & Bio | Contact |
| Chairman and CEO | Karl Groth | Network |
| COO and Director | Peggy Farley | Network |
| CFO and Director | Mark Borman | Network |
Competition
Competitive Landscape for Bioheart, Inc.
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior products. Large companies have economies of scale in manufacturing and R&D. Small companies can compete successfully by specializing in a particular market segment, or through technical innovation. To read the full description, subscribe now.Top Bioheart, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!